AKT1 and metabolic disease: Indeed, impairment of PI3K/AKT and MAPK signaling may affect glucose and lipid homeostasis [51,52], whereas RAP1 signaling participates in the mechanistic pathway linking overnutrition to obesity and metabolic disorders [53].